Compounds > haloperidol

haloperidol and 7-hydroxy-2-(n-n-propyl-n-(3-iodo-2'-propenyl)-amino)tetralin

haloperidol has been researched along with 7-hydroxy-2-(n-n-propyl-n-(3-iodo-2'-propenyl)-amino)tetralin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Foulon, C; Kung, HF; Kung, MP1
Burris, KD; Chumpradit, S; Frederick, D; Garner, S; Kung, HF; Kung, MP; Molinoff, PB1
Joyce, JN1
Blanchet, PJ; Lévesque, D; Mahmoudi, S1

Other Studies

4 other study(ies) available for haloperidol and 7-hydroxy-2-(n-n-propyl-n-(3-iodo-2'-propenyl)-amino)tetralin

ArticleYear
Synthesis of (R,S)-2'-trans-7-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'- propenyl)-amino]tetralin (trans-7-OH-PIPAT): a new D3 dopamine receptor ligand.
    Journal of medicinal chemistry, 1993, May-14, Volume: 36, Issue:10

    Topics: Binding Sites; Dopamine Agents; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Salicylamides; Stereoisomerism; Tetrahydronaphthalenes

1993
Characterization of binding sites for [125I]R(+)trans-7-OH-PIPAT in rat brain.
    Naunyn-Schmiedeberg's archives of pharmacology, 1994, Volume: 350, Issue:6

    Topics: Animals; Autoradiography; Haloperidol; Hippocampus; Male; Prosencephalon; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Tetrahydronaphthalenes

1994
D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period.
    Synapse (New York, N.Y.), 2001, Volume: 40, Issue:2

    Topics: Animals; Brain; Dopamine Antagonists; Drug Administration Schedule; Haloperidol; Iodine Radioisotopes; Male; Neurons; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA, Messenger; Spiperone; Substance Withdrawal Syndrome; Tetrahydronaphthalenes; Time Factors; Tritium; Up-Regulation

2001
Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model.
    Movement disorders : official journal of the Movement Disorder Society, 2014, Volume: 29, Issue:9

    Topics: Animals; Antipsychotic Agents; Brain; Cebus; Clozapine; Disease Models, Animal; Dopamine Antagonists; Enkephalins; Female; Haloperidol; Iodine Radioisotopes; Movement Disorders; Neurons; Ovariectomy; Protein Binding; Receptors, Dopamine D2; Receptors, Dopamine D3; Sulpiride; Tetrahydronaphthalenes; Up-Regulation

2014